We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$40.5M +$53.1K +1,088 +0.1%
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$25.9M
BlackRock
3
BlackRock
New York
$19.5M -$535K -10,969 -2%
ABG
4
Ally Bridge Group
New York
$15.4M
Vanguard Group
5
Vanguard Group
Pennsylvania
$13.3M +$1.03M +21,040 +8%
FP
6
Flagship Pioneering
Massachusetts
$13.1M
OFM
7
Omega Fund Management
Massachusetts
$11.2M +$1.16M +23,788 +10%
AG
8
Artal Group
Luxembourg
$8.94M +$1.46M +30,000 +18%
SB
9
Samsara BioCapital
California
$8.62M
O
10
OrbiMed
New York
$8.21M
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$8.05M +$4.63M +94,770 +111%
ACM
12
Altium Capital Management
New York
$5.69M +$954K +19,547 +18%
State Street
13
State Street
Massachusetts
$4.99M +$568K +11,632 +12%
SCM
14
Sio Capital Management
New York
$4.03M +$492K +10,068 +13%
RCM
15
RA Capital Management
Massachusetts
$4.02M
Geode Capital Management
16
Geode Capital Management
Massachusetts
$3.83M -$531K -10,880 -11%
CS
17
Candriam SCA
Luxembourg
$2.61M
Northern Trust
18
Northern Trust
Illinois
$2.35M -$145K -2,974 -5%
Goldman Sachs
19
Goldman Sachs
New York
$2.19M -$52.3K -1,072 -2%
Millennium Management
20
Millennium Management
New York
$1.41M -$1.18M -24,133 -43%
Los Angeles Capital Management
21
Los Angeles Capital Management
California
$1.16M -$61.4K -1,257 -5%
Morgan Stanley
22
Morgan Stanley
New York
$1.02M -$849K -17,391 -43%
Nuveen
23
Nuveen
North Carolina
$1.01M +$88.2K +1,807 +10%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$953K +$326K +6,674 +46%
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
$918K -$505K -10,335 -33%